Empire Genomics LLC-医療機器分野:企業M&A・提携分析

◆英語タイトル:Empire Genomics LLC - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011091
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Empire Genomics LLC (Genomics) is a medical device company that offers molecular diagnostic solutions. The company offers ID labs products, fish probes, BAC clones, genotyping and circulating tumor cell products. Its services comprise array CGH, gene expression, clinical and custom services. Genomics’s ID lab products include cytogenetics media, cytogenetics probes, IHC and histology reagents; immuno assays, cytokines and flow cytometry; and molecular biology products. The company offers clinical services such as cytogenetics, PCR, fluorescence in-situ hybridization, next generation sequencing, gene expression, microarray services. It serves research, clinical and drug discovery companies. Genomics is headquartered in Buffalo, New York, the US.

Empire Genomics LLC – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Empire Genomics LLC, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Empire Genomics LLC, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Empire Genomics LLC, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Empire Genomics LLC, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Empire Genomics LLC, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Empire Genomics LLC, Medical Equipment, Deal Details 10
Venture Financing 10
Empire Genomics Raises USD1.8 Million in Venture Financing 10
Empire Genomics Raises USD15 Million in Venture Financing 11
Empire Genomics Raises USD1 Million in Venture Financing 12
Partnerships 13
Empire Genomics Enters Into Licensing Agreement With Cornell University For Genomic Biomarker 13
Empire Genomics Enters Into Licensing Agreement With Emory University For Genomic Biomarkers 14
Empire Genomics Enters into Partnership with KromaTiD 15
Empire Genomics Enters into Distribution Agreement with HemaTone Beijing 16
Empire Genomics LLC – Key Competitors 17
Empire Genomics LLC – Key Employees 18
Empire Genomics LLC – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Product News 20
May 10, 2016: New York State Grants Clinical Lab Permit to Empire Genomics 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Empire Genomics LLC, Medical Equipment, Key Facts 2
Empire Genomics LLC, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Empire Genomics LLC, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Empire Genomics LLC, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Empire Genomics LLC, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Empire Genomics LLC, Deals By Market, 2011 to YTD 2017 8
Empire Genomics LLC, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Empire Genomics Raises USD1.8 Million in Venture Financing 10
Empire Genomics Raises USD15 Million in Venture Financing 11
Empire Genomics Raises USD1 Million in Venture Financing 12
Empire Genomics Enters Into Licensing Agreement With Cornell University For Genomic Biomarker 13
Empire Genomics Enters Into Licensing Agreement With Emory University For Genomic Biomarkers 14
Empire Genomics Enters into Partnership with KromaTiD 15
Empire Genomics Enters into Distribution Agreement with HemaTone Beijing 16
Empire Genomics LLC, Key Competitors 17
Empire Genomics LLC, Key Employees 18
Empire Genomics LLC, Subsidiaries 19

★海外企業調査レポート[Empire Genomics LLC-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • QuadraMed Corp:医療機器:M&Aディール及び事業提携情報
    Summary Quadramed Corporation (Quadramed), is a N. Harris Computer Corp., is a healthcare technologies and service provider. It provides solutions to various healthcare organizations to improve the safety, efficiency and quality of patient care. The company's solutions enable its clients in streamli …
  • Flint Group:企業の戦略・SWOT・財務分析
    Flint Group - Strategy, SWOT and Corporate Finance Report Summary Flint Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Aquestive Therapeutics Inc (AQST):製薬・医療:M&Aディール及び事業提携情報
    Summary Aquestive Therapeutics Inc (Aquestive Therapeutics) is a pharmaceutical company that discovers, develops and commercializes prescription drug products and a pipeline of prescription formulations. The company offers PharmFilm a drug delivery platform that delivers existing prescription produc …
  • BroadVision Inc (BVSN):企業の財務・戦略的SWOT分析
    Summary BroadVision Inc (BroadVision) operates as a digital technology service provider. It provides products such as vmoso. The company vmos product offers communication and collaboration, knowledge management, collaborative process management and enterprise integration. BroadVision also offers sec …
  • Spicers Limited (SRS):企業の財務・戦略的SWOT分析
    Spicers Limited (SRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • JSC IC Allianz:企業の戦略・SWOT・財務分析
    JSC IC Allianz - Strategy, SWOT and Corporate Finance Report Summary JSC IC Allianz - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Inogen Inc (INGN):企業の財務・戦略的SWOT分析
    Summary Inogen Inc (Inogen) is a medical device company that offers oxygen therapy technology solutions. The company offers products which include g2 portable oxygen concentrator system, g3 portable oxygen concentrator system, home oxygen concentrator and accessory items. Its products are used in bo …
  • Nisshinbo Holdings Inc. (3105):企業の財務・戦略的SWOT分析
    Nisshinbo Holdings Inc. (3105) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Akers Biosciences Inc (AKER):製薬・医療:M&Aディール及び事業提携情報
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRO …
  • Boardwalk Pipeline Partners LP:企業の戦略・SWOT・財務分析
    Boardwalk Pipeline Partners LP - Strategy, SWOT and Corporate Finance Report Summary Boardwalk Pipeline Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • HCA Healthcare, Inc.:企業の戦略・SWOT・財務分析
    HCA Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report Summary HCA Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Technopromexport:企業の戦略的SWOT分析
    Technopromexport - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Tereos SA:企業の戦略的SWOT分析
    Tereos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • ThreeD Capital:企業のM&A・事業提携・投資動向
    ThreeD Capital - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ThreeD Capital Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Challenge Group Holdings PTE. LTD.:企業の戦略・SWOT・財務分析
    Challenge Group Holdings PTE. LTD. - Strategy, SWOT and Corporate Finance Report Summary Challenge Group Holdings PTE. LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Relievant MedSystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Relievant MedSystems Inc (Relievant) is a medical device company developing new minimally-invasive solutions for the treatment of chronic low back pain (CLBP). The company's Intracept system, a minimally invasive procedure uses radiofrequency energy delivered through a small access tube into …
  • Southern Minnesota Municipal Power Agency:企業の戦略的SWOT分析
    Southern Minnesota Municipal Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Vericel Corp (VCEL)-医療機器分野:企業M&A・提携分析
    Summary Vericel Corp (Vericel) formerly Aastrom Biosciences, Inc. is a medical device company that develops patient-specific expanded cellular therapies to repair and regenerate damaged tissue for the treatment of severe, chronic ischemic cardiovascular diseases. It markets two autologous cell thera …
  • CoreCivic, Inc. (CXW):企業の財務・戦略的SWOT分析
    CoreCivic, Inc. (CXW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Valentino Fashion Group S.p.A:企業の戦略・SWOT・財務情報
    Valentino Fashion Group S.p.A - Strategy, SWOT and Corporate Finance Report Summary Valentino Fashion Group S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆